Logo do repositório
 
Publicação

Effectiveness of double-puncture temporomandibular joint arthrocentesis with viscosupplementation in different categories of severity – a prospective study

dc.contributor.authorÂngelo, David
dc.contributor.authorSanz, David
dc.contributor.authorCardoso, Henrique José
dc.date.accessioned2023-10-18T15:03:17Z
dc.date.available2023-10-18T15:03:17Z
dc.date.issued2023
dc.description© 2023 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.pt_PT
dc.description.abstractThis 3-year prospective study evaluated the efficacy of temporomandibular joint (TMJ) arthrocentesis with viscosupplementation in different severity stages based on the Dimitroulis classification (categories 2–4 were included). TMJ arthrocentesis was performed under local anaesthesia, and the protocol consisted of a double-puncture technique with lavage of ≥150 cc Ringer Lactate plus viscosupplementation. Incobotulinum toxin A was administered 10–15 days preoperatively in patients with concomitant masticatory myalgia. The primary outcome was TMJ pain, assessed by visual analogue scale (VAS, 0–10), and the secondary outcomes were the maximum mouth opening (MMO, mm) and myalgia degree (0–3). All outcomes were assessed on the intervention day (T0) and after the procedure (T1) (minimum 1 month and then 3 months, 6 months, 1 year and every year since). A total of 108 patients were enrolled (mean age of 43.1 ± 18.9 years); 86 (80%) were women and 22 (20%) were men. Preoperative pain was 4.02 ± 3.12 (mean ± SD), MMO was 38.10 ± 9.56 (mean ± SD) and myalgia degree was 1.80 ± 1.18 (mean ± SD). After an average of 215.4 days (31–1253 days), a statistically significant improvement of pain (P < 0.0001), MMO (P = 0.005) and myalgia degree (P < 0.0001) was observed. The overall successful outcome of TMJ arthrocentesis with viscosupplementation was 76%. The authors observed increased arthrocentesis effectiveness and success rate with viscosupplementation in Dimitroulis category 2 (88.6%) compared to 3–4 (71.4%). An association was found between arthrocentesis with viscosupplementation failure and painful myalgia (ρ = 0.477; P < 0.0001). Thirteen patients (12%) underwent a second TMJ intervention after finalising the present trial. With a low complication rate, TMJ arthrocentesis with viscosupplementation led to an overall benefit for all the included patients. This study reinforces the important role of minimally invasive TMJ arthrocentesis as a first treatment option, with better results in the early stages compared to more severe stages.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationJournal of Cranio-Maxillo-Facial Surgery Volume 51, Issue 11, November 2023, Pages 659-667pt_PT
dc.identifier.doi10.1016/j.jcms.2023.09.010pt_PT
dc.identifier.urihttp://hdl.handle.net/10451/59889
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relation.publisherversionhttps://www.sciencedirect.com/journal/journal-of-cranio-maxillofacial-surgerypt_PT
dc.subjectTemporomandibular joint disorderspt_PT
dc.subjectTMJ arthrocentesispt_PT
dc.subjectViscosupplementationpt_PT
dc.subjectMinimally invasive surgical procedurespt_PT
dc.titleEffectiveness of double-puncture temporomandibular joint arthrocentesis with viscosupplementation in different categories of severity – a prospective studypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleJournal of Cranio-Maxillofacial Surgerypt_PT
person.familyNameÂngelo
person.givenNameDavid
person.identifier.ciencia-id2C1B-F1D5-5A08
person.identifier.orcid0000-0001-8411-9946
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication17926c30-4672-46f2-a819-657463e3c725
relation.isAuthorOfPublication.latestForDiscovery17926c30-4672-46f2-a819-657463e3c725

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Effectiveness_double.pdf
Tamanho:
2.16 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: